200 related articles for article (PubMed ID: 20816538)
21. Current and developing therapeutic agents in the treatment of Chagas disease.
Apt W
Drug Des Devel Ther; 2010 Sep; 4():243-53. PubMed ID: 20957215
[TBL] [Abstract][Full Text] [Related]
22. American trypanosomiasis (Chagas disease).
Rassi A; Rassi A; Marcondes de Rezende J
Infect Dis Clin North Am; 2012 Jun; 26(2):275-91. PubMed ID: 22632639
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of Chagas disease with benznidazole and thioctic acid].
Roldán EJ
Medicina (B Aires); 2005; 65(1):85-6; author reply 86-7. PubMed ID: 15830800
[No Abstract] [Full Text] [Related]
24. Severe drug-induced liver injury (DILI) associated with benznidazole therapy for Chagas' disease.
Giancola ML; Corpolongo A; Comandini UV; Del Nonno F; Montalbano M; Petrone A; Carrara S; Mariano A; Beccacece A; Maffongelli G; Nicastri E
J Antimicrob Chemother; 2022 Nov; 77(12):3515-3517. PubMed ID: 36173378
[No Abstract] [Full Text] [Related]
25. [Interventional study in the natural evolution of Chagas disease. Evaluation of specific antiparasitic treatment. Retrospective-prospective study of antiparasitic therapy].
Gallerano RR; Sosa RR
Rev Fac Cien Med Univ Nac Cordoba; 2000; 57(2):135-62. PubMed ID: 12934232
[TBL] [Abstract][Full Text] [Related]
26. Long-term comparative pharmacovigilance of orally transmitted Chagas disease: first report.
Alarcón de Noya B; Ruiz-Guevara R; Noya O; Castro J; Ossenkopp J; Díaz-Bello Z; Colmenares C; Suárez JA; Noya-Alarcón O; Naranjo L; Gutiérrez H; Quinci G; Torres J
Expert Rev Anti Infect Ther; 2017 Mar; 15(3):319-325. PubMed ID: 28132566
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of Chagas disease].
Abitbol H
An R Acad Nac Med (Madr); 1981; 98(4):755-8. PubMed ID: 6808853
[No Abstract] [Full Text] [Related]
28. Chagas disease. American trypanosomiasis.
Kirchhoff LV
Infect Dis Clin North Am; 1993 Sep; 7(3):487-502. PubMed ID: 8254156
[TBL] [Abstract][Full Text] [Related]
29. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.
Viotti R; Vigliano C; Lococo B; Alvarez MG; Petti M; Bertocchi G; Armenti A
Expert Rev Anti Infect Ther; 2009 Mar; 7(2):157-63. PubMed ID: 19254164
[TBL] [Abstract][Full Text] [Related]
30. Treatment with Fenofibrate plus a low dose of Benznidazole attenuates cardiac dysfunction in experimental Chagas disease.
Cevey ÁC; Mirkin GA; Donato M; Rada MJ; Penas FN; Gelpi RJ; Goren NB
Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):378-387. PubMed ID: 29040909
[TBL] [Abstract][Full Text] [Related]
31. New drugs for neglected infectious diseases: Chagas' disease.
Machado FS; Tanowitz HB; Teixeira MM
Br J Pharmacol; 2010 May; 160(2):258-9. PubMed ID: 20423339
[TBL] [Abstract][Full Text] [Related]
32. [Tolerance to benzonidazole during the etiological treatment of Chagas' disease].
de Arruda Júnior ER
Arq Bras Cardiol; 1987 Jun; 48(6):395-7. PubMed ID: 3128252
[No Abstract] [Full Text] [Related]
33. Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment.
Pérez-Molina JA; Sojo-Dorado J; Norman F; Monge-Maillo B; Díaz-Menéndez M; Albajar-Viñas P; López-Vélez R
Acta Trop; 2013 Aug; 127(2):101-4. PubMed ID: 23583863
[TBL] [Abstract][Full Text] [Related]
34. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.
Molina I; Gómez i Prat J; Salvador F; Treviño B; Sulleiro E; Serre N; Pou D; Roure S; Cabezos J; Valerio L; Blanco-Grau A; Sánchez-Montalvá A; Vidal X; Pahissa A
N Engl J Med; 2014 May; 370(20):1899-908. PubMed ID: 24827034
[TBL] [Abstract][Full Text] [Related]
35. Tolerance and safety of nifurtimox in patients with chronic chagas disease.
Jackson Y; Alirol E; Getaz L; Wolff H; Combescure C; Chappuis F
Clin Infect Dis; 2010 Nov; 51(10):e69-75. PubMed ID: 20932171
[TBL] [Abstract][Full Text] [Related]
36. New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: a Pilot Short-Term Follow-Up Study with Adult Patients.
Álvarez MG; Hernández Y; Bertocchi G; Fernández M; Lococo B; Ramírez JC; Cura C; Albizu CL; Schijman A; Abril M; Sosa-Estani S; Viotti R
Antimicrob Agents Chemother; 2016 Feb; 60(2):833-7. PubMed ID: 26596935
[TBL] [Abstract][Full Text] [Related]
37. Recognizing and meeting the challenge of Chagas disease in the USA.
Bowling J; Walter EA
Expert Rev Anti Infect Ther; 2009 Dec; 7(10):1223-34. PubMed ID: 19968514
[TBL] [Abstract][Full Text] [Related]
38. Contributions of toxicology to the problem of Chagas' disease (American Trypanosomiasis)--a year 2000 update.
Castro JA
Biomed Environ Sci; 2000 Dec; 13(4):271-9. PubMed ID: 11351860
[No Abstract] [Full Text] [Related]
39. The need of a neonatal preparation for Chagas disease.
Sosa-Estani S; Belizan JM; Althabe F; Rubinstein A
PLoS Med; 2005 Nov; 2(11):e387. PubMed ID: 16288560
[No Abstract] [Full Text] [Related]
40. Therapeutic efficacy of allopurinol in patients with chronic Chagas' disease.
Gallerano RH; Marr JJ; Sosa RR
Am J Trop Med Hyg; 1990 Aug; 43(2):159-66. PubMed ID: 2117857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
